Artal Group S.A. - SPRINGWORKS THERAPEUTICS INC ownership

SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 134 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of SPRINGWORKS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$42,000
-11.8%
1,816,6200.0%1.80%
+22.0%
Q2 2023$47,632
+1.8%
1,816,620
-0.0%
1.48%
-46.9%
Q1 2023$46,779
-10.1%
1,817,349
-9.1%
2.78%
-4.3%
Q4 2022$52,020
-99.9%
2,000,000
-2.6%
2.90%
+16.2%
Q3 2022$58,584,000
+164.4%
2,053,403
+128.2%
2.50%
+111.3%
Q2 2022$22,158,000
-53.8%
900,000
+5.9%
1.18%
-41.1%
Q1 2022$47,974,000
-8.9%
850,0000.0%2.01%
+40.5%
Q4 2021$52,683,000
+38.4%
850,000
+41.7%
1.43%
+67.8%
Q3 2021$38,064,000
-7.6%
600,000
+20.0%
0.85%
+1.9%
Q2 2021$41,205,000
+40.0%
500,000
+25.0%
0.84%
+60.8%
Q1 2021$29,428,000
-9.8%
400,000
-11.1%
0.52%
-25.8%
Q4 2020$32,634,000
+140.2%
450,000
+57.9%
0.70%
+112.4%
Q3 2020$13,586,000
+7.8%
285,000
-5.0%
0.33%
-6.5%
Q2 2020$12,600,000
+33.3%
300,000
-14.3%
0.35%
-11.5%
Q1 2020$9,450,000
-29.9%
350,0000.0%0.40%
-23.3%
Q4 2019$13,472,000
+101.4%
350,000
+13.4%
0.52%
+94.0%
Q3 2019$6,689,000308,5260.27%
Other shareholders
SPRINGWORKS THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 3,081,307$79,3139.91%
Finepoint Capital LP 614,231$15,810,3066.04%
M28 Capital Management LP 197,700$5,088,7985.75%
Boxer Capital, LLC 3,421,541$88,0704.33%
Deep Track Capital, LP 3,100,000$79,794,0003.28%
EcoR1 Capital, LLC 3,460,208$89,065,7542.87%
Artal Group S.A. 1,817,349$46,7792.78%
Orbimed Advisors 4,498,900$115,801,6862.27%
Perceptive Advisors 2,079,352$53,522,5201.58%
SPHERA FUNDS MANAGEMENT LTD. 317,625$8,175,6681.37%
View complete list of SPRINGWORKS THERAPEUTICS INC shareholders